Prot# A3921021: Mltctr, Phase 2, Opn-Lbl, Controlled, Extension Study for Stage 1 Subjects of Study A3921009 to Evaluate Long-Term Safety & Efficacy of CP-690,550 vs. Tacrolimus, When Co-Administered w/ Mycophenolate Mofetil in Renal Allograft Recipients

Project: Research project

Project Details

StatusFinished
Effective start/end date12/12/05 → 9/1/14

Funding

  • Pfizer Inc. (A3921021)